Do you want to read an article? Please log in or register.
Novo Nordisk unterstützt die Patientenorganisation Swiss Diabetes Kids
Type 1 DiabetesPediatric Diabetes
Pharma News
Related content
Pharma News
Type 1 DiabetesPediatric Diabetes
Novo Nordisk soutient l'association de patients Swiss Diabetes Kids
Pediatric Diabetes
Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study
Pediatr Diabetes.
Duca LM, Reboussin BA, Pihoker C, Imperatore G, Saydah S, Mayer-Davis E, Rewers A, Dabelea D
doi: 10.1111/pedi.12809.
Type 1 DiabetesDiabetic ComplicationsPediatric Diabetes
Significant reduction of ketoacidosis at diabetes onset in children and adolescents with type 1 diabetes - the Stuttgart Diabetes Awareness Campaign, Germany
Pediatr Diabetes.
Holder M, Ehehalt S
doi: 10.1111/pedi.13064.
Type 1 DiabetesType 2 Diabetes
Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
Diabetes Care.
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Dolan LM, Marcovina S, Linder B, Liese AD, Pop-Busui R, Feldman EL
doi: 10.2337/dc17-0179.
COMMENTED
Diabetes - GeneralType 2 DiabetesGlycemic Control
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Diabetes Care.
de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G
doi: 10.2337/dci17-0026.
Diabetes - GeneralType 2 DiabetesGlycemic Control
Changes in Diabetes Medication Regimens and Glycemic Control in Adolescents and Young Adults with Youth Onset Type 2 Diabetes: the SEARCH for Diabetes in Youth Study
Pediatr Diabetes.
Pinto CA, Stafford JM, Wang T, Shankar RR, Lawrence JM, Kim G, Pihoker C, D'Agostino RB Jr, Dabelea D
doi: 10.1111/pedi.12691.
COMMENTED
Type 2 Diabetes
Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Griffin SJ, Rutten GEHM, Khunti K, Witte DR, Lauritzen T, Sharp SJ, Dalsgaard EM, Davies MJ, Irving GJ, Vos RC, Webb DR, Wareham NJ, Sandbæk A
doi: 10.1016/S2213-8587(19)30349-3.
Type 2 DiabetesPediatric Diabetes
Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for youth with Type 2 diabetes: reliability and validity
Diabet Med.
Varni JW, Delamater AM, Hood KK, Raymond JK, Chang NT, Driscoll KA, Wong JC, Yi-Frazier JP, Grishman EK, Faith MA, Corathers SD, Kichler JC, Miller JL, Doskey EM, Aguirre VP, Heffer RW, Wilson DP; Pediatric Quality of Life Inventory 3.2 Diabetes Module Testing Study Consortium
doi: 10.1111/dme.13841.
COMMENTED
Type 2 DiabetesGlycemic Control
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Care.
Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio DA, Davies MJ
doi: 10.2337/dci19-0066.